✦ LIBER ✦
Bevacizumab for choroidal neovascularization secondary to pathologic myopia: Is there a decline of the treatment efficacy after 2 years?
✍ Scribed by Bogomil Voykov; Faik Gelisken; Werner Inhoffen; Michael Voelker; Karl Ulrich Bartz-Schmidt; Focke Ziemssen
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 234 KB
- Volume
- 248
- Category
- Article
- ISSN
- 0065-6100
No coin nor oath required. For personal study only.